Mutations in IDH were found to be in almost all cases of secondary glioblastoma, as reported by Parsons et al. IDH mutations exist in high numbers in secondary glioblastomas and grade II and III gliomas but are rare in primary glioblastomas [25]. This evidence concerns the gene IDH1 and central nervous system cancer.